Dihydro-β-erythroidine hydrobromide
Cat. No.：YN360192
| 产品名称: | Dihydro-β-erythroidine hydrobromide |
| CAS No.: | 29734-68-7 |
| Chemical Name: | (2S,13bS)-2,3,5,6,8,9,10,13-Octahydro-2-methoxy-1H,12H-Benzo[i]pyrano[3,4-g]indolizin-12-one Hydrobromide; 2,7-Dihydro-β-erythroidine Hydrobromide; [2S-(2R*,13bR*)]-2,3,5,6,8,9,10,13-Octahydro-2-methoxy-1H,12H-Benzo[i]pyrano[3,4-g]indolizin-12-one Hydrobr |
| Synonyms: | DHβE hydrobromide |
| 分子量: | 356.25 |
| 分子式: | C₁₆H₂₂BrNO₃ |
| SMILES: | CO[C@@H]1C[C@]23C(CC4=O)=C(CO4)CCN2CCC3=CC1.Br |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Dihydro-β-erythroidine (DHβE) hydrobromide 是一种有效竞争性的，具有口服活性的神经nAChRs拮抗剂。Dihydro-β-erythroidine hydrobromide 对 α4β4 和 α4β2 有选择性，IC50分别为 0.19 和 0.37 μM。具有抗抑郁类活性。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Curzon, P., et al.: Brain Res. 714, 185 (1996)
Bancroft, A. and Levin, E. D.: Neuropharmacol.. 39, 2770 (2000)
